rs200888878
Variant summary
Our verdict is Likely benign. Variant got -5 ACMG points: 0P and 5B. BP4_StrongBS1_Supporting
The NM_006302.3(MOGS):c.1124C>T(p.Thr375Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00012 in 1,614,252 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_006302.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -5 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MOGS | NM_006302.3 | c.1124C>T | p.Thr375Ile | missense_variant | 4/4 | ENST00000448666.7 | NP_006293.2 | |
MOGS | NM_001146158.2 | c.806C>T | p.Thr269Ile | missense_variant | 5/5 | NP_001139630.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MOGS | ENST00000448666.7 | c.1124C>T | p.Thr375Ile | missense_variant | 4/4 | 1 | NM_006302.3 | ENSP00000410992 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000670 AC: 102AN: 152246Hom.: 1 Cov.: 33
GnomAD3 exomes AF: 0.000260 AC: 65AN: 249528Hom.: 0 AF XY: 0.000266 AC XY: 36AN XY: 135388
GnomAD4 exome AF: 0.0000622 AC: 91AN: 1461888Hom.: 1 Cov.: 31 AF XY: 0.0000646 AC XY: 47AN XY: 727242
GnomAD4 genome AF: 0.000669 AC: 102AN: 152364Hom.: 1 Cov.: 33 AF XY: 0.000886 AC XY: 66AN XY: 74506
ClinVar
Submissions by phenotype
MOGS-congenital disorder of glycosylation Uncertain:2
Uncertain significance, criteria provided, single submitter | clinical testing | Center for Genomics, Ann and Robert H. Lurie Children's Hospital of Chicago | Mar 30, 2021 | MOGS NM_006302.2 exon 4 p.Thr375Ile (c.1124C>T): This variant has not been reported in the literature but is present in 0.1% (53/33582) of Latino alleles in the Genome Aggregation Database (http://gnomad.broadinstitute.org/rs200888878). This variant amino acid Isoleucine (Ile) is present in >5 species; this suggests that this variant may not impact the protein. Additional computational prediction tools do not suggest an impact. In summary, data on this variant is insufficient for disease classification. Therefore, the clinical significance of this variant is uncertain. - |
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 31, 2024 | This sequence change replaces threonine, which is neutral and polar, with isoleucine, which is neutral and non-polar, at codon 375 of the MOGS protein (p.Thr375Ile). This variant is present in population databases (rs200888878, gnomAD 0.2%). This variant has not been reported in the literature in individuals affected with MOGS-related conditions. ClinVar contains an entry for this variant (Variation ID: 534243). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt MOGS protein function with a negative predictive value of 80%. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at